Funded Tech Companies
Karuna Therapeutics
Karuna Therapeutics, based in Boston, received equity investments from Fidelity Management & Research Company, Alexandria Venture Investments and Sands Capital Management.
Company Overview
Company Name
Karuna Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
33 Arch St. 3110
Boston, MA 02110
USA
Boston, MA 02110
USA
Phone
Website
Email Address
Company Background Information
Overview
Karuna Therapeutics (Nasdaq: KRTX) is a clinical-stage company targeting muscarinic cholinergic receptors for the treatment of psychosis and cognitive impairment across central nervous system (CNS) disorders.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/28/2019
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Paul
Chief Financial Officer
Troy Ignelzi
Chief Medical Officer
Stephen Brannan
Chief Operating Officer
Andrew Miller
Vice President
Giorgio Attardo
VP - Finance
Jason Brown
VP - R & D
Christian Felder
Company Investors
- Fidelity Management & Research Company
- Alexandria Venture Investments
- Sands Capital Management
- Partner Fund Management
- Pivotal bioVenture Partners
- Arch Venture Partners (Robert Nelsen)
- Sofinnova Ventures (James Healey)
- The Wellcome Trust
- Eventide Asset Management
- PureTech Ventures
- Private Investors (Steven Paul)
Browse more funded tech companies:
Karta | Karyopharm Therapeutics
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs